Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-AnalysisPlain-Language Summary

Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-AnalysisPlain-Language Summary

Rationale and Objective: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy (renin-angiotensin-aldosterone system [RAAS] inhibitor) to control proteinuria in primary and genetic focal segmental glomerulosclerosis (FSGS) follows guidelines based on other proteinuria-relat...

Full description

Bibliographic Details
Main Authors: Kirk N. Campbell, Natali Pennese, Andrea Zaffalon, Barbara Magalhaes, Marina Faiella, Dawn J. Caster, Jai Radhakrishnan, Vladimir Tesar, Howard Trachtman
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Kidney Medicine
Subjects:
End-stage kidney disease
end-stage renal disease
focal segmental glomerulosclerosis
proteinuria
renin-angiotensin-aldosterone system inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S259005952200070X

Internet

http://www.sciencedirect.com/science/article/pii/S259005952200070X

Similar Items